Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTime Finance Regulatory News (TIME)

Share Price Information for Time Finance (TIME)

Share Price is delayed by 15 minutes
Get Live Data
46.00    0.75 (1.66%)
Bid:
45.00
Ask:
47.00
Spread: 2.00 (4.444%)
Market Cap: £42.17m
TIME Live PriceLast checked at - London Stock Exchange

Intraday Time Finance Share Chart

Year-end Trading Update

16 Jun 2021 07:00

RNS Number : 0646C
Time Finance PLC
16 June 2021
 

16 June 2021

 

Time Finance plc

("Time Finance", the "Group" or the "Company")

 

Year-end Trading Update

and

Strategic Update and Dividend Policy

 

Time Finance plc, the AIM listed independent specialist finance provider, is pleased to issue the following unaudited trading update ahead of the publication of its final results for the financial year ended 31 May 2021.

 

The Company also announces a strategic update. This sets out the Group's renewed focus on its core products, its ambition for significant organic growth, and to become a leading alternative multi-product independent SME funder helping UK businesses recover and grow post-Covid. This follows the appointment of Ed Rimmer as the Company's permanent CEO, announced on 10 June 2021.

 

Trading update

 

The financial year to 31 May 2021 was profitable for the Group with it continuing to demonstrate the resilience and diversification of its lending book, further strengthening its balance sheet and improving liquidity. This was achieved despite trading being severely impacted by the ongoing effect of the COVID-19 pandemic which included a further period of interruption to normal trading conditions as a result of Lockdown 3.

 

Highlights:

 

· Board restructured and strengthened with the appointments of Ed Rimmer and Tanya Raynes as CEO and Non-Executive Director respectively.

· Rebranding to Time Finance, consolidating the Group's activities under a single national brand. 

· System enhancements, including online introductions, automated links to credit referencing agencies and to a new fraud detection service, embedded within the Group's IT infrastructure. 

· Accreditations from The British Business Bank to provide Coronavirus Business Interruption Loan Scheme ("CBILS") and, latterly, Recovery Loan Scheme ("RLS") providing Government-backed financing to UK SMEs.

• Continued focus on diversification and spread of risk in lending, with largest sector exposure now accounting for less than 5% and top ten sectors less than 25% of the total lending book.

· New business origination for the financial year of approximately £103m (FY20: £147m). Approximately £47m (46%) was written on 'own-book' and £56m (54%.) was brokered on for commission income (FY20; £54m (37%) and £93m (63%) respectively).

· Revenue for the year expected to be approximately £24.1m (FY20: £29.2m) of which approximately 85% is from lending activities and 15% from broking activities (FY20: 80% and 20% respectively).

· Profit Before Tax, Exceptional Items and Share-Based Payments ("PBTE") for the year expected to be approximately £3.0m (FY20: £3.0m).

· Blended cost of borrowing maintained at approximately 4% (FY20: 4%).

· Net portfolio write-offs representing circa 1.5% of the gross lending portfolio (FY20: 1.0%).

· Net Tangible Assets at 31 May 21 of approximately £28.3m (31 May 20: £26.5m).

· Net lending book at 31 May 21 of approximately £98.8m (31 May 20: £107.7m).

· Cash and cash equivalents of approximately £8.3m at 31 May 21 (31 May 20: £1.3m).

· Forbearance granted reduced by over 95 per cent during course of year to under £1m.

· Deal arrears at 31 May 21 now standing at below pre-pandemic levels seen at February 2020 having reduced by approximately 40 per cent from 31 May 2020.

· Credit Risk Provisions marginally increased to approximately £5.3m or 5.3% of the net lending book (31 May 20: £5.1m or 4.6%).

· Good visibility of future revenue with "unearned income" at 31 May 21 of approximately £14.5m (31 May 20: £15.2m).

 

Strategic Update

 

The Group is also pleased to issue the following Strategic Update. This involves the adding of significant scale with the clear goal for Time Finance of becoming a leading alternative multi-product independent SME funder, helping UK businesses to recover and grow post-Covid.

 

In doing so, the Group's principal strategic objectives are to:

 

· More than double the Group's gross lending book organically from its current level to approximately £250 million by 31 May 2025.

· Over the same timeframe achieve organic-led growth to be in excess of the Group's 2019 pre-Covid levels of over £30m Revenue and £8m of PBTE.

· Apply a clear focus on the core business-to-business offerings of asset, loan and invoice finance.

· Refocus the Group's proposition to primarily offer more secured own-book lending.

· To focus on funding on the Group's own balance sheet wherever possible, while maintaining the flexibility to act as a broker to other lenders when prudent to do so.

 

The Group will therefore very much remain a non-bank alternative finance provider to UK SMEs. There will, however, be a far greater focus on lending its three core products to UK businesses on its own book wherever possible, increasing overall margins and providing greater visibility of earnings. This will be underpinned by taking greater security and increasing the average deal size, enabling the business to position itself as a lender to a wider range of established clients.

 

Ed Rimmer, Chief Executive Officer, commented:

 

"I firmly believe a number of fantastic opportunities lie ahead for Time Finance. The foundations of the Group are extremely strong and my first three months back in the business have convinced me that evolution not revolution is the right next step on the Group's journey. We now have a clear vision focussing on the three key products that are very much in our DNA - asset finance, invoice finance and loan finance - with an exciting growth plan to return to and in time exceed pre-Covid performance. I strongly believe this is the direction that will add real value to all our stakeholders and I am looking forward to the challenges ahead."

 

John Newman, Chairman, added:

 

"The impact of the global pandemic made the financial year to 31 May 2021 a challenging one for the Group, especially with the impact of a further lockdown after our half year results were published. The period has, however, also demonstrated the resilience and robust nature of the Group, highlighting its ability to withstand the significant headwinds it has faced and bringing to the fore the benefits of being a multi-product provider of finance to UK SMEs, spread across multiple business sectors, with the ability to act as both a funder and a broker. The Group starts the new financial year on more solid foundations having navigated the impact of COVID-19 well, emerging with a stronger balance sheet and better liquidity. Whilst the economic environment remains uncertain, we are cautiously optimistic by the positive signs we are seeing across the markets in which we operate and the Group is well-positioned to deliver future shareholder value."

 

Updated Dividend Policy

 

As highlighted above, the Group's strategy is to generate organic growth that will more than double the Group's lending book over the next few years through a renewed focus on its core offering of business-to-business financing. A key factor in the successful delivery of this strategy and the growth of shareholder value will be maximising the deployment of its cash resources to the growth of, and investment in, the business rather than to dividends at the current time. The Board therefore confirms that, due to the impact of the COVID-19 pandemic, the deferred interim dividend of 0.36 pence per share previously declared for the half year period ended 30 November 2019, and originally due be paid on 12 May 2020 to shareholders on the register at 17 April 2020, will not be paid. The dividend policy will be regularly reviewed during the course of the new financial year as the Group continues its recovery from the effects of the pandemic.

 

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 (as amended), which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018. Upon publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

For further information, please contact:

 

 

 

Time Finance plc

 

Ed Rimmer, Chief Executive Officer

01225 474230

James Roberts, Chief Financial Officer

01225 474230

 

 

Cenkos Securities plc (NOMAD)

 

Max Hartley / Ben Jeynes (Nomad)

Julian Morse (Sales)

0207 397 8900

 

 

Walbrook PR

0207 933 8780

Paul Vann / Nicholas Johnson

07768 807631

 

paul.vann@walbrookpr.com

 

About Time Finance:

Time Finance's strategy is to focus on providing or arranging the finance UK SMEs require to fund their businesses and arranging vehicle and property-backed finance for consumers. The multi-product range for SMEs includes asset, vehicle, loan and invoice finance facilities. The Group operates a "hybrid" lending and broking model enabling it to optimize business levels through market and economic cycles.

 

More information is available on the Company website www.timefinance.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFMATMTTBMIB
Date   Source Headline
15th Nov 202312:54 pmRNSChange of Nominated Adviser & Corporate Broker
9th Nov 20237:00 amRNSTrading Update
7th Nov 202311:45 amRNSResult of AGM
23rd Oct 20238:30 amRNSDirector Share Purchase
19th Oct 20237:00 amRNSDirector Share Purchase
11th Oct 20237:00 amRNSDirector Share Purchases
3rd Oct 20237:00 amRNSDirector/PDMR Shareholdings: Vesting of Options
27th Sep 20238:30 amRNSNotice of AGM
26th Sep 20237:00 amRNSQ1 Trading Update
26th Sep 20237:00 amRNSFinal Results
19th Sep 20237:00 amRNSAppointment of Independent Non-Executive Directors
12th Sep 20237:00 amRNSOwn-Book Update, Notice of Results, Pres & AGM
11th Jul 20237:00 amRNSDirector Share Purchase
29th Jun 20237:00 amRNSFull Year Trading Update
24th May 20239:04 amRNSDelivery of First Asset-Based Lending Facility
3rd May 20237:00 amRNSTrading Update & Notice of Final Results
8th Mar 20237:00 amRNSQ3 Trading Update: Pre-Tax Profits up 172%
9th Feb 202311:40 amRNSHolding in Company
26th Jan 202311:05 amRNSSecond Price Monitoring Extn
26th Jan 202311:00 amRNSPrice Monitoring Extension
26th Jan 20237:00 amRNSInterim Results
20th Dec 20221:24 pmRNSExercise of Options & Director/PDMR Shareholding
16th Dec 20227:00 amRNSH1 Trading Update & Notice of Interim Results
14th Nov 20227:00 amRNSDirector Share Purchases
3rd Nov 20227:00 amRNSMelloLondon Investor Conference
31st Oct 20222:00 pmRNSResult of AGM
19th Oct 20227:00 amRNSOwn Book Lending Portfolio reaches record £145m
5th Oct 20227:00 amRNSDirector Share Purchase
4th Oct 202212:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20222:15 pmRNSNotice of AGM
22nd Sep 20227:00 amRNSQ1 Trading Update
22nd Sep 20227:00 amRNSFinal Results for the year ended 31 May 2022
15th Sep 20227:00 amRNSNotice of Results & Q1 Update and Presentation
6th Sep 20227:00 amRNSAppointments Strengthen Asset Finance Division
22nd Jul 20227:00 amRNSNew LTIP & Director/PDMR Shareholding
19th Jul 20227:02 amRNSDirector Share Purchases
18th Jul 20227:00 amRNSDirector Share Purchase
7th Jul 20227:00 amRNSTrading Update & Notice of Final Results
10th Jun 20227:00 amRNSNotice of Trading Update and Investor Presentation
5th May 20229:19 amRNSHolding in Company
27th Apr 20223:28 pmRNSHolding in Company
27th Apr 202212:51 pmRNSHolding in Company
26th Apr 20223:30 pmRNSTR-1 Holding in Company
26th Apr 20229:36 amRNSTR-1 Holding in Company
14th Feb 202210:00 amRNSExercise of Options & Director/PDMR Shareholdings
20th Jan 20227:00 amRNSInterim Results
5th Jan 20227:00 amRNSNotice of Interim Results Investor Presentation
15th Dec 20217:00 amRNSH1 Trading Update & Notice of Interim Results
21st Oct 20213:40 pmRNSResult of AGM & Directorate Change
1st Oct 20217:00 amRNSVesting of Share Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.